<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
  <url>
    <loc>https://whattonoh.jp/</loc>
  </url>
  <url>
    <loc>https://whattonoh.jp/news</loc>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles</loc>
  </url>
  <url>
    <loc>https://whattonoh.jp/data</loc>
  </url>
  <url>
    <loc>https://whattonoh.jp/data/kessan</loc>
  </url>
  <url>
    <loc>https://whattonoh.jp/data/kessan/suii</loc>
  </url>
  <url>
    <loc>https://whattonoh.jp/data/kaigi</loc>
  </url>
  <url>
    <loc>https://whattonoh.jp/data/yakka</loc>
  </url>
  <url>
    <loc>https://whattonoh.jp/data/releases</loc>
  </url>
  <url>
    <loc>https://whattonoh.jp/data/deals</loc>
  </url>
  <url>
    <loc>https://whattonoh.jp/data/chiken</loc>
  </url>
  <url>
    <loc>https://whattonoh.jp/data/chiken/ct</loc>
  </url>
  <url>
    <loc>https://whattonoh.jp/data/kaigi/shusai</loc>
  </url>
  <url>
    <loc>https://whattonoh.jp/data/kaigi/topic/yakka-shusai</loc>
  </url>
  <url>
    <loc>https://whattonoh.jp/data/kaigi/topic/shinki-shonin</loc>
  </url>
  <url>
    <loc>https://whattonoh.jp/data/kaigi/topic/hiyotaikoka</loc>
  </url>
  <url>
    <loc>https://whattonoh.jp/contact</loc>
  </url>
  <url>
    <loc>https://whattonoh.jp/about</loc>
  </url>
  <url>
    <loc>https://whattonoh.jp/privacy</loc>
  </url>
  <url>
    <loc>https://whattonoh.jp/terms</loc>
  </url>
  <url>
    <loc>https://whattonoh.jp/topics/yakka</loc>
  </url>
  <url>
    <loc>https://whattonoh.jp/topics/policy</loc>
  </url>
  <url>
    <loc>https://whattonoh.jp/topics/mfn</loc>
  </url>
  <url>
    <loc>https://whattonoh.jp/topics/approval</loc>
  </url>
  <url>
    <loc>https://whattonoh.jp/topics/data</loc>
  </url>
  <url>
    <loc>https://whattonoh.jp/topics/launch</loc>
  </url>
  <url>
    <loc>https://whattonoh.jp/topics/earnings</loc>
  </url>
  <url>
    <loc>https://whattonoh.jp/topics/deal</loc>
  </url>
  <url>
    <loc>https://whattonoh.jp/topics/obesity</loc>
  </url>
  <url>
    <loc>https://whattonoh.jp/topics/china</loc>
  </url>
  <url>
    <loc>https://whattonoh.jp/topics/distribution</loc>
  </url>
  <url>
    <loc>https://whattonoh.jp/topics/commercial</loc>
  </url>
  <url>
    <loc>https://whattonoh.jp/topics/digital</loc>
  </url>
  <url>
    <loc>https://whattonoh.jp/topics/healthcare</loc>
  </url>
  <url>
    <loc>https://whattonoh.jp/topics/global</loc>
  </url>
  <url>
    <loc>https://whattonoh.jp/topics/other</loc>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/isomorphic-labs-5billion-series-c</loc>
    <lastmod>2026-11-20</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/generic-makers-stability-rating-a-38-companies</loc>
    <lastmod>2026-11-19</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/mfn-price-policy-europe-drug-launch</loc>
    <lastmod>2026-11-18</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/ivonescimab-fda-crl-os-2026</loc>
    <lastmod>2026-11-17</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/yondai-iiyaku-oroshisho-fy26-chukan-2026</loc>
    <lastmod>2026-11-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/helios-hlcm051-ards-approval-5years</loc>
    <lastmod>2026-11-15</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/ojemda-toborafenib-japanese-data-approval</loc>
    <lastmod>2026-11-14</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/germany-drug-price-us-mfn-harvard-study</loc>
    <lastmod>2026-11-13</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/access-to-medicine-index-2026-novartis-gsk</loc>
    <lastmod>2026-11-12</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/bayer-asundexian-fda-stroke-approval-2026</loc>
    <lastmod>2026-11-11</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/lilly-tirzepatide-us-japan-contrast-2026</loc>
    <lastmod>2026-11-10</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/aha-2026-lp-a-inflammation-no-cardiovascular-benefit</loc>
    <lastmod>2026-11-09</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/shinnyaku-16-seibun-november-2026</loc>
    <lastmod>2026-11-08</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/rasonque-pancreatic-cancer-launch-2026</loc>
    <lastmod>2026-11-07</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/mof-yakka-seido-yokyu-2026</loc>
    <lastmod>2026-11-06</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/astrazeneca-rhythm-pharmaceuticals-acquisition-bid</loc>
    <lastmod>2026-11-05</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/pfizer-q3-2026-corona-exclusion-7percent</loc>
    <lastmod>2026-11-05</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/disease-awareness-top-share-benefit</loc>
    <lastmod>2026-11-04</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/abbvie-q3-2026-skyrizi-rinvoq-next</loc>
    <lastmod>2026-11-03</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/sanofi-dupixent-q3-2026</loc>
    <lastmod>2026-11-02</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/astrazeneca-rsg-cost-reduction-3q-2026</loc>
    <lastmod>2026-11-01</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/lilly-q3-2026-earnings</loc>
    <lastmod>2026-10-31</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/takeda-fy2026-h1-results-organic-decline</loc>
    <lastmod>2026-10-30</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/anthropic-mithril-medicine-acquisition-drug-development</loc>
    <lastmod>2026-10-29</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/chugai-q3-2026-earnings</loc>
    <lastmod>2026-10-28</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/takeda-adc-gastric-cancer-3rd-line-os</loc>
    <lastmod>2026-10-27</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/amgen-tarlatamab-dellphi-305-sclc-2026</loc>
    <lastmod>2026-10-26</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/alexion-stories-of-silent-days-rare-disease</loc>
    <lastmod>2026-10-25</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/openevidence-jama-study-2026</loc>
    <lastmod>2026-10-24</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/icer-2026-launch-price-access-report</loc>
    <lastmod>2026-10-23</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/adl-regenerative-medicine-policy-proposal-2026</loc>
    <lastmod>2026-10-22</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/roche-deutschland-investment-hold-gkv-reform</loc>
    <lastmod>2026-10-21</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/chmp-foundayo-rasonque-october-2026</loc>
    <lastmod>2026-10-20</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/efpia-drug-loss-policy-reform-2026</loc>
    <lastmod>2026-10-19</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/stemilac-honshounin-2026</loc>
    <lastmod>2026-10-17</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/fda-rare-disease-framework-initiative-2026</loc>
    <lastmod>2026-10-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/bms-phase-3-admilparant-ryz101-2026</loc>
    <lastmod>2026-10-15</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/shinnyaku-11-seibun-yakka-syusai-2026-10</loc>
    <lastmod>2026-10-13</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/cost-calc-5-drugs-premium-zero</loc>
    <lastmod>2026-10-08</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/shionogi-intrabio-acquisition</loc>
    <lastmod>2026-10-07</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/rohto-midterm-plan-upward-revision</loc>
    <lastmod>2026-10-06</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/ips-heart-sheet-reheart-first-transplant</loc>
    <lastmod>2026-10-05</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/daiichi-datroway-ivonescimab-p3</loc>
    <lastmod>2026-10-04</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/toho-hd-phc-acquisition-proposal</loc>
    <lastmod>2026-10-03</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/cost-effectiveness-price-adjustment-expansion</loc>
    <lastmod>2026-10-02</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/mhlw-white-paper-2026</loc>
    <lastmod>2026-10-01</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/mhlw-negative-margin-price-increase</loc>
    <lastmod>2026-09-30</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/lilly-change-the-course-glp1-lmic</loc>
    <lastmod>2026-09-29</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/novo-nordisk-2030-strategy-selfpay</loc>
    <lastmod>2026-09-28</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/pubmed-linked-discoveries</loc>
    <lastmod>2026-09-27</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/gsk-uk-pmcpa-grossly-misleading</loc>
    <lastmod>2026-09-26</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/china-first-in-class-quarter-target</loc>
    <lastmod>2026-09-25</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/otsuka-ionis-fus-als-p3</loc>
    <lastmod>2026-09-24</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/europe-pharma-chairs-innovation-letter</loc>
    <lastmod>2026-09-23</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/pfizer-lilly-mfn-agreement-disclosed</loc>
    <lastmod>2026-09-22</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/akuugo-first-patient-after-2years</loc>
    <lastmod>2026-09-21</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/fda-pmda-real-time-clinical-trial</loc>
    <lastmod>2026-09-20</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/fda-ultragenyx-gene-therapy-approval</loc>
    <lastmod>2026-09-19</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/shionogi-us-xocova-campaign</loc>
    <lastmod>2026-09-18</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/pharma-groups-cost-effectiveness-freeze</loc>
    <lastmod>2026-09-17</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/mfn-lancet-model-study</loc>
    <lastmod>2026-09-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/enhertu-lung-first-line-os-negative</loc>
    <lastmod>2026-09-14</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/ucb-bimzelx-us-tv-ad-top</loc>
    <lastmod>2026-09-13</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/pmda-project-orbis</loc>
    <lastmod>2026-09-12</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/chugai-yanagisawa-lasker-award-2026</loc>
    <lastmod>2026-09-11</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/drug-pricing-earthquake-commercial-report</loc>
    <lastmod>2026-09-10</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/novartis-three-setbacks-share-drop</loc>
    <lastmod>2026-09-09</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/novo-ziltivekimab-two-trials-halted</loc>
    <lastmod>2026-09-08</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/uk-pharma-investment-withdrawal-1year</loc>
    <lastmod>2026-09-07</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/whitehouse-lilly-medicare-blockbuster</loc>
    <lastmod>2026-09-06</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/drug-loss-86-products-mhlw-review</loc>
    <lastmod>2026-09-05</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/silchester-medipal-egm-proposal</loc>
    <lastmod>2026-09-04</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/mhlw-budget-request-fy2027-36-6cho</loc>
    <lastmod>2026-09-03</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/orexin-agonist-cns-glp1-competition</loc>
    <lastmod>2026-09-02</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/mfn-9-more-companies-astellas-kyowa</loc>
    <lastmod>2026-09-01</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/mhlw-promotion-violation-report-2026</loc>
    <lastmod>2026-08-31</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/mounjaro-cv-risk-indication-us</loc>
    <lastmod>2026-08-30</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/iryohi-fy2025-record-49-2cho</loc>
    <lastmod>2026-08-29</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/revolution-medicines-daraxonrasib-fda</loc>
    <lastmod>2026-08-28</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/chuikyo-mfn-industry-testimony</loc>
    <lastmod>2026-08-27</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/daiichi-sankyo-commercialization-unit</loc>
    <lastmod>2026-08-26</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/switzerland-mfn-reimbursement-withheld</loc>
    <lastmod>2026-08-25</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/rare-disease-patient-group-reputation-2026</loc>
    <lastmod>2026-08-24</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/generic-drug-lobby-development-abandonment</loc>
    <lastmod>2026-08-23</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/whitehouse-mfn-drug-price-drop</loc>
    <lastmod>2026-08-22</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/moderna-mrna-cancer-vaccine-p3</loc>
    <lastmod>2026-08-21</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/tanabe-delcimerago-leo-pharma</loc>
    <lastmod>2026-08-20</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/iqvia-sales-data-trend</loc>
    <lastmod>2026-08-19</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/argenx-vyvgart-myositis-p23</loc>
    <lastmod>2026-08-18</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/jmdc-fy26-q1</loc>
    <lastmod>2026-08-17</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/icer-astrazeneca-hypertension</loc>
    <lastmod>2026-08-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/lilly-retatrutide-illegal-sales-suit</loc>
    <lastmod>2026-08-15</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/pharma-q2-2026-earnings-rush</loc>
    <lastmod>2026-08-14</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/revolution-medicines-beone-asia-deal</loc>
    <lastmod>2026-08-13</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/pharma-tv-ad-spending-july-2026</loc>
    <lastmod>2026-08-12</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/big-four-wholesalers-fy26-q1-earnings</loc>
    <lastmod>2026-08-11</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/m3-fy26q1-earnings-decline</loc>
    <lastmod>2026-08-10</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/pfizer-q2-2026-earnings-25b-cost-cut</loc>
    <lastmod>2026-08-09</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/novo-vs-lilly-glp1-q2-2026</loc>
    <lastmod>2026-08-07</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/dupixent-yakkka-saisan-2026</loc>
    <lastmod>2026-08-06</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/az-bms-merger-bad-idea</loc>
    <lastmod>2026-08-05</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/lilly-mounjaro-yakka-hikisage-2026</loc>
    <lastmod>2026-08-04</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/astrazeneca-bms-merger-talks-4000-billion</loc>
    <lastmod>2026-08-03</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/alnylam-q2-2026-earnings-guidance-cut</loc>
    <lastmod>2026-08-02</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/abbvie-skyrizi-humira-record-sales</loc>
    <lastmod>2026-08-01</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/astrazeneca-h1-2026-earnings-oncology</loc>
    <lastmod>2026-07-31</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/lilly-p3i-ranking-first</loc>
    <lastmod>2026-07-30</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/gsk-q2-2026-accelerate-growth</loc>
    <lastmod>2026-07-29</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/ge-biosimilar-vision-2040</loc>
    <lastmod>2026-07-28</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/chugai-h1-2026-earnings</loc>
    <lastmod>2026-07-27</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/novo-lilly-glp-1-false-advertising-lawsuit</loc>
    <lastmod>2026-07-26</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/takeda-obepiorextan-china-first-approval</loc>
    <lastmod>2026-07-25</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/jma-koutai-2026-3-point-objection</loc>
    <lastmod>2026-07-24</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/trump-generic-tariff-reshoring-2028</loc>
    <lastmod>2026-07-23</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/koutai-houshin-2026-ei-kaigi-kettei</loc>
    <lastmod>2026-07-22</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/nvidia-big-pharma-ai-infrastructure-partnerships</loc>
    <lastmod>2026-07-21</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/merck-lipfendla-cnpv-approval</loc>
    <lastmod>2026-07-20</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/lancet-human-security-diplomacy-2040</loc>
    <lastmod>2026-07-19</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/lancet-2026-japan-uhc-vision-2040</loc>
    <lastmod>2026-07-18</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/jj-tremfya-stelara-q2-2026</loc>
    <lastmod>2026-07-17</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/jaskaid-ipf-pff-launch-2026</loc>
    <lastmod>2026-07-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/germany-mandatory-rebates-15-5-percent</loc>
    <lastmod>2026-07-15</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/souyaku-kanmin-kyogikai-mfn-scenario</loc>
    <lastmod>2026-07-14</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/glp-1-usage-us-2026-four-fold-increase</loc>
    <lastmod>2026-07-13</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/mckinsey-ai-drug-discovery-linear-gates-learning-loops</loc>
    <lastmod>2026-07-12</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/jimin-ishin-shakaihosho-kaikaku-13</loc>
    <lastmod>2026-07-11</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/astrazeneca-wainua-attr-cm-trial-failure</loc>
    <lastmod>2026-07-10</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/national-university-hospitals-deficit-2025</loc>
    <lastmod>2026-07-09</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/cancer-patient-reputation-ranking-2026</loc>
    <lastmod>2026-07-08</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/oral-glp1-foundayo-vs-wegovy-us</loc>
    <lastmod>2026-07-07</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/domestic-drug-sales-ranking-2025</loc>
    <lastmod>2026-07-06</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/tanabe-pharma-fabless-towayakuhin</loc>
    <lastmod>2026-07-05</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/roche-divarasib-kras-g12c-phase3</loc>
    <lastmod>2026-07-04</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/car-t-solid-tumor-china-approval-2026</loc>
    <lastmod>2026-07-03</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/2040-nendo-soshoku-chikara-kyoka-naikakufu</loc>
    <lastmod>2026-07-02</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/tavneos-nejm-retract-2026</loc>
    <lastmod>2026-07-01</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/clinical-trials-2026-h2</loc>
    <lastmod>2026-06-30</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/regenerative-medicine-self-paid-survey-fy2025</loc>
    <lastmod>2026-06-29</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/nature-medicine-immunotherapy-timing-retraction</loc>
    <lastmod>2026-06-28</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/global-pharma-market-2-trillion-2032</loc>
    <lastmod>2026-06-27</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/nihon-seichou-senryaku-souyaku-64chouen</loc>
    <lastmod>2026-06-26</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/lilly-foundayo-eu-mfn-telehealth</loc>
    <lastmod>2026-06-25</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/mr-problematic-communication-88-percent</loc>
    <lastmod>2026-06-24</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/abbvie-apogee-109-billion-acquisition</loc>
    <lastmod>2026-06-23</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/foreign-executives-higher-pay-than-ceo</loc>
    <lastmod>2026-06-22</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/moderna-mflusiqa-fda-vrbpac-approval</loc>
    <lastmod>2026-06-21</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/us-investigates-germany-drug-pricing-ustr-301</loc>
    <lastmod>2026-06-20</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/takeda-weber-ceo-compensation-evaluation</loc>
    <lastmod>2026-06-19</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/elevidys-yakka-3oku-yakkan-akaji</loc>
    <lastmod>2026-06-18</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/takeda-obeplorexton-sleep-2026</loc>
    <lastmod>2026-06-17</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/japan-korea-research-rankings-2026</loc>
    <lastmod>2026-06-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/us-dtc-ads-ranking-may-2026-immunology</loc>
    <lastmod>2026-06-15</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/takeda-zasocitinib-head-to-head-tyk2</loc>
    <lastmod>2026-06-14</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/pwc-us-medical-cost-trend-2027</loc>
    <lastmod>2026-06-13</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/parabilis-medicines-ipo-6-7-billion</loc>
    <lastmod>2026-06-12</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/gsk-nuvalent-106-billion-cancer-acquisition</loc>
    <lastmod>2026-06-11</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/biopharma-ceo-pay-2025-top25</loc>
    <lastmod>2026-06-10</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/ada-2026-obesity-market-retatrutide-novo</loc>
    <lastmod>2026-06-09</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/gni-ayumi-acquisition-2026</loc>
    <lastmod>2026-06-08</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/shionogi-endeavor-ride-adhd-dts-2026</loc>
    <lastmod>2026-06-07</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/takeda-amitiza-antitrust-verdict-2026</loc>
    <lastmod>2026-06-06</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/nhk-regenerative-medicine-free-care-2026</loc>
    <lastmod>2026-06-05</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/roto-avi-torikubigiian-2025</loc>
    <lastmod>2026-06-04</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/daraxonrasib-asco-2024-pancreatic-cancer</loc>
    <lastmod>2026-06-02</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/biopharma-ceo-japan-innovation-crisis-2026</loc>
    <lastmod>2026-06-01</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/glp1-jiyushindairyou-mondai</loc>
    <lastmod>2026-05-31</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/pfizer-innovent-1-6trn-yen-deal</loc>
    <lastmod>2026-05-30</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/lilly-vaccine-infectious-disease-reentry-2026</loc>
    <lastmod>2026-05-29</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/astellas-csp2026-strategic-products</loc>
    <lastmod>2026-05-28</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/eisai-3l-medium-term-plan-2028</loc>
    <lastmod>2026-05-27</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/novo-nordisk-ai-india-bangalore-gcc</loc>
    <lastmod>2026-05-26</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/lilly-retatrutide-p3-triumph-1-2026</loc>
    <lastmod>2026-05-25</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/tirzepatide-glp1-worldleader-2025</loc>
    <lastmod>2026-05-24</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/wholesale-distributors-mid-term-strategy</loc>
    <lastmod>2026-05-23</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/pharma-4-wholesalers-fy2026-results</loc>
    <lastmod>2026-05-22</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/kissei-tabneos-fda-approval-withdrawal</loc>
    <lastmod>2026-05-20</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/ips-cell-drug-yakka-2024</loc>
    <lastmod>2026-05-19</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/glp1-jiyushinryo-kiseikinai</loc>
    <lastmod>2026-05-18</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/manjaro-yakka-25pct-2026-passs</loc>
    <lastmod>2026-05-17</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/takeda-fy2025-earnings-webber-ceo</loc>
    <lastmod>2026-05-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/teijin-takeda-diabetes-acquisition-writedown</loc>
    <lastmod>2026-05-15</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/teijin-2026-healthcare-segment-earnings</loc>
    <lastmod>2026-05-14</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/daiichisankyo-6ki-chukan-2030</loc>
    <lastmod>2026-05-13</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/daiichi-sankyo-fy2025-earnings-revision</loc>
    <lastmod>2026-05-12</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/ono-pharma-2026-fosiega-optivo-cliff</loc>
    <lastmod>2026-05-11</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/seivisc-meniscus-regenerative-medicine-approval</loc>
    <lastmod>2026-05-10</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/kyowakirin-q1-2026-earnings-rare-disease</loc>
    <lastmod>2026-05-09</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/lilly-glp1-market-share-q1-2026</loc>
    <lastmod>2026-05-08</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/china-bioventure-license-deal-2025</loc>
    <lastmod>2026-05-07</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/shionogi-8800oku-deal-2025</loc>
    <lastmod>2026-05-06</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/toho-hd-chuki-keiei-keikaku-2028</loc>
    <lastmod>2026-05-05</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/vcube-listing-delisting-2026</loc>
    <lastmod>2026-05-04</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/m3-2025-earnings-ai-strategy</loc>
    <lastmod>2026-05-03</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/lecanemab-880-oku-2025</loc>
    <lastmod>2026-05-02</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/astellas-fy2025-earnings-xtandi-patent-cliff</loc>
    <lastmod>2026-05-01</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/canbas-cbp501-pancreatic-cancer-ema-phase3-approval</loc>
    <lastmod>2026-11-20</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/jnj-caplyta-lumateperone-bipolar-mania-fda-snda</loc>
    <lastmod>2026-11-20</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/sanofi-weighs-takeover-insmed-bloomberg</loc>
    <lastmod>2026-11-20</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/abbvie-puerto-rico-barceloneta-manufacturing-investment</loc>
    <lastmod>2026-11-20</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/novartis-2026-2031-midterm-guidance-sales-cagr</loc>
    <lastmod>2026-11-19</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/teva-us-administration-medicaid-pricing-agreement</loc>
    <lastmod>2026-11-19</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/mhlw-icvs-tokyo-clinic-emergency-order-dendritic-cell</loc>
    <lastmod>2026-11-19</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/sanofi-vaxrabeo-rabies-eu-approval-all-ages</loc>
    <lastmod>2026-11-19</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/innovacell-icef15-ices13-us-patent-muscle-derived-cells</loc>
    <lastmod>2026-11-19</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/gsk-velzatinib-gist-japan-orphan-drug-designation</loc>
    <lastmod>2026-11-19</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/gsk-momelotinib-vexas-orphan-drug-designation-japan</loc>
    <lastmod>2026-11-19</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/sanofi-infilbray-venglustat-gaucher-type3-fda-approval</loc>
    <lastmod>2026-11-19</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/teva-eric-hughes-rd-leadership-departure</loc>
    <lastmod>2026-11-19</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/eisai-biogen-leqembi-lecanemab-leader-real-world-ctad</loc>
    <lastmod>2026-11-19</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/tanabe-pharma-neuroderm-wind-down</loc>
    <lastmod>2026-11-19</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/geda-long-listed-drug-information-proposal</loc>
    <lastmod>2026-11-19</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/mhlw-system-unauthorized-access</loc>
    <lastmod>2026-11-18</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/nippon-shinyaku-rice-donation</loc>
    <lastmod>2026-11-18</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/jcr-pharma-factory-tour</loc>
    <lastmod>2026-11-18</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/tims-tms008-acute-kidney</loc>
    <lastmod>2026-11-18</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/novartis-pelagibresib-myelofibrosis</loc>
    <lastmod>2026-11-18</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/jpma-efpia-chuikyo-regret</loc>
    <lastmod>2026-11-18</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/innovacell-jetro-interview</loc>
    <lastmod>2026-11-18</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/fujirebio-lumipulse-alzheimers</loc>
    <lastmod>2026-11-18</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/juntendo-jmdc-ai-partnership</loc>
    <lastmod>2026-11-18</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/rohto-izumi-preventive-health</loc>
    <lastmod>2026-11-18</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/shionogi-intrabio-aqneursa-acquisition</loc>
    <lastmod>2026-11-18</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/pmda-irb-registration-update</loc>
    <lastmod>2026-11-18</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/novo-cagrisema-bone-finding</loc>
    <lastmod>2026-11-18</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/mandus-rembast-npc-type-c</loc>
    <lastmod>2026-11-18</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/gsk-narcarmi-alk-positive-nsclc-fda-approval</loc>
    <lastmod>2026-11-18</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/jnj-trufill-membrane12</loc>
    <lastmod>2026-11-18</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/viatris-pacira-acquisition</loc>
    <lastmod>2026-11-18</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/tiim-smtp-44d-diabetic-kidney</loc>
    <lastmod>2026-11-17</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/novartis-medicine-access-index-2026</loc>
    <lastmod>2026-11-17</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/gilead-2026-q3-hiv-18-percent</loc>
    <lastmod>2026-11-17</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/jpma-approval-database-update</loc>
    <lastmod>2026-11-17</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/medii-hokudai-hsct-e-consult</loc>
    <lastmod>2026-11-17</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/mochida-fujieda-women-health-agreement</loc>
    <lastmod>2026-11-17</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/ribomiclabs-umedaptanib-achondroplasia</loc>
    <lastmod>2026-11-17</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/solasia-sp05-isofol-investment</loc>
    <lastmod>2026-11-17</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/roche-wilsardry-breast-cancer</loc>
    <lastmod>2026-11-17</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/stella-pharma-interim-results</loc>
    <lastmod>2026-11-17</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/eisai-lecanemab-ctad-5year</loc>
    <lastmod>2026-11-17</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/shionogi-delgocitinib-china-approval</loc>
    <lastmod>2026-11-17</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/meiji-seika-arcturus-mrna</loc>
    <lastmod>2026-11-17</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/pmda-approval-2026</loc>
    <lastmod>2026-11-17</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/fda-cosentyx-polymyalgia</loc>
    <lastmod>2026-11-17</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/teva-igalmi-fda-approval</loc>
    <lastmod>2026-11-17</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/jnj-ollin-acquisition</loc>
    <lastmod>2026-11-17</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/pfizer-tsukaiza-biliary-approval</loc>
    <lastmod>2026-11-17</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/novo-semaglutide-pediatric-obesity</loc>
    <lastmod>2026-11-17</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/bcg-us-mfn-europe-new-drug</loc>
    <lastmod>2026-11-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/phrma-drug-price-cge-withdrawal</loc>
    <lastmod>2026-11-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/zs-pharma-growth-2035-rd-ratio</loc>
    <lastmod>2026-11-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/takeda-anti-cldn18-gastric-designation</loc>
    <lastmod>2026-11-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/kyorin-trofinetide-rett-distribution</loc>
    <lastmod>2026-11-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/kyorin-acadia-rett-syndrome</loc>
    <lastmod>2026-11-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/meiji-seika-lesafilipin-cin-approval</loc>
    <lastmod>2026-11-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/sterilac-conditional-approval-first</loc>
    <lastmod>2026-11-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/lilly-foundayo-osa-phase3-ahi-reduction</loc>
    <lastmod>2026-11-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/lilly-jayperca-cll-approval</loc>
    <lastmod>2026-11-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/novartis-pluvicto-mcrpc-expansion</loc>
    <lastmod>2026-11-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/amgen-blinatumomab-all-approval</loc>
    <lastmod>2026-11-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/roche-gadzia-primary-membranous-fda</loc>
    <lastmod>2026-11-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/servier-onivyde-pancreatic</loc>
    <lastmod>2026-11-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/argenics-unnatural-products</loc>
    <lastmod>2026-11-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/generic-supply-category-a</loc>
    <lastmod>2026-11-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/sanbiotherapeutics-acuogo</loc>
    <lastmod>2026-11-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/novo-jadec-wdd2026</loc>
    <lastmod>2026-11-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/stella-steboroniun-angiosarcoma</loc>
    <lastmod>2026-11-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/boeringer-hernexeos-nsclc</loc>
    <lastmod>2026-11-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/alexion-gefurulimab-myasthenia</loc>
    <lastmod>2026-11-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/astrazeneca-imfinzi-bladder</loc>
    <lastmod>2026-11-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/astrazeneca-baxfendy-hypertension</loc>
    <lastmod>2026-11-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/twocel-gmsc-knee-phase3</loc>
    <lastmod>2026-11-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/cagrisema-obesity-weight-loss</loc>
    <lastmod>2026-11-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/diabetes-acute-hospitalization</loc>
    <lastmod>2026-11-15</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/generic-supply-evaluation-c</loc>
    <lastmod>2026-11-15</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/drug-price-reform-proposal</loc>
    <lastmod>2026-11-15</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/semaglutide-food-thinking</loc>
    <lastmod>2026-11-15</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/cagrisema-weight-loss-phase3</loc>
    <lastmod>2026-11-15</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/heartseed-q3-loss</loc>
    <lastmod>2026-11-15</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/ema-chmp-november-7-drugs</loc>
    <lastmod>2026-11-14</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/roche-gadjibro-sle-chmp</loc>
    <lastmod>2026-11-14</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/novo-frehe-go-hemophilia-eu</loc>
    <lastmod>2026-11-14</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/chmp-bexsero-10-booster</loc>
    <lastmod>2026-11-14</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/chmp-novartis-cosentyx-pyoderma</loc>
    <lastmod>2026-11-14</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/toho-cvc-colonct-ai-bms</loc>
    <lastmod>2026-11-14</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/nano-holdings-loss-expansion</loc>
    <lastmod>2026-11-13</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/takeda-ash-lower-risk-mds</loc>
    <lastmod>2026-11-13</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/sawai-ghd-operating-profit-revision</loc>
    <lastmod>2026-11-13</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/takeda-obeporalextan-award</loc>
    <lastmod>2026-11-13</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/otsuka-inofeed-enteral-launch</loc>
    <lastmod>2026-11-13</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/laqualia-q3-operating-loss</loc>
    <lastmod>2026-11-13</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/qualips-2q-rehardt-transplant</loc>
    <lastmod>2026-11-13</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/gni-ayumi-pharma-consolidation</loc>
    <lastmod>2026-11-13</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/nippon-shinyaku-interim-revision</loc>
    <lastmod>2026-11-13</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/ipsen-ojenda-glioma-launch</loc>
    <lastmod>2026-11-13</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/pfizer-ritlecro-vitiligo-approval</loc>
    <lastmod>2026-11-13</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/otsuka-ziprelertinib-egfr-ex20ins-fda</loc>
    <lastmod>2026-11-13</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/ono-exicokupuri-antiepileptic-launch</loc>
    <lastmod>2026-11-13</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/takeda-elahia-fralpha-ovarian</loc>
    <lastmod>2026-11-13</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/eisai-lecanemab-pen-launch</loc>
    <lastmod>2026-11-13</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/jnj-icotide-psoriasis-launch</loc>
    <lastmod>2026-11-13</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/lundbeck-viepti-migraine-injection</loc>
    <lastmod>2026-11-13</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/novartis-remibrutinib-ciae-52week</loc>
    <lastmod>2026-11-13</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/suzuken-medimo-ai-chat-free</loc>
    <lastmod>2026-11-13</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/takeda-ozemiflow-nt1-us-launch</loc>
    <lastmod>2026-11-13</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/viatris-fortune-best-workplace-consecutive</loc>
    <lastmod>2026-11-13</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/efpia-japan-new-chairman-ucb-kikuchi</loc>
    <lastmod>2026-11-12</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/chugai-ir-award-359-companies</loc>
    <lastmod>2026-11-12</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/solasia-3q-sales-revision</loc>
    <lastmod>2026-11-12</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/helios-ards-japan-phase3</loc>
    <lastmod>2026-11-12</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/china-iep-integrated-evidence</loc>
    <lastmod>2026-11-12</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/otsuka-hd-ir-award</loc>
    <lastmod>2026-11-12</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/t-dxd-uterine-carcinosarcoma-approval</loc>
    <lastmod>2026-11-12</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/mysignal-cancer-risk-3000-centers</loc>
    <lastmod>2026-11-12</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/cerebral-palsy-shed-one-year</loc>
    <lastmod>2026-11-12</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/nice-anal-cancer-retifanlimab</loc>
    <lastmod>2026-11-12</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/pmda-pediatric-drug-qa</loc>
    <lastmod>2026-11-12</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/chuikyo-drug-price-2027-mfn-policy</loc>
    <lastmod>2026-11-12</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/novo-diabetes-foundation-200m-10years</loc>
    <lastmod>2026-11-12</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/sjogrens-dazolaribep-phase3-primary</loc>
    <lastmod>2026-11-12</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/teva-rd-day-2030-innovation-drugs</loc>
    <lastmod>2026-11-12</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/chuikyo-cost-increase-drug-price</loc>
    <lastmod>2026-11-12</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/globaldata-mfn-europe-new-drug-27pct</loc>
    <lastmod>2026-11-11</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/jma-fiscal-review-patient-burden</loc>
    <lastmod>2026-11-11</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/takeda-tyk2-inhibitor-tofacitinib-psoriasis</loc>
    <lastmod>2026-11-11</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/shionogi-cefiderocol-link</loc>
    <lastmod>2026-11-11</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/toho-holdings-oyster-therapeutics</loc>
    <lastmod>2026-11-11</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/peptidrm-q3-revenue-operating-loss</loc>
    <lastmod>2026-11-11</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/msd-creslovimab-routine-immunization</loc>
    <lastmod>2026-11-11</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/lilly-phrma-obesity-forum</loc>
    <lastmod>2026-11-11</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/m3-ai-physician-rollout</loc>
    <lastmod>2026-11-11</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/toho-mid-term-operating-profit</loc>
    <lastmod>2026-11-11</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/kissei-iselti-taiwan-endometriosis</loc>
    <lastmod>2026-11-11</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/fronteo-boston-ai-drug-discovery</loc>
    <lastmod>2026-11-11</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/innovacell-icef-enrollment-2026</loc>
    <lastmod>2026-11-11</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/solasia-sp05-colorectal-no-dlt</loc>
    <lastmod>2026-11-11</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/jnj-ash-myeloma-third-line</loc>
    <lastmod>2026-11-11</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/ncc-gastric-esophageal-73-percent</loc>
    <lastmod>2026-11-11</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/pwc-amed-data-secondary-use</loc>
    <lastmod>2026-11-11</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/urinary-microrna-colorectal-craif</loc>
    <lastmod>2026-11-11</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/novartis-q3-sales-profit-guidance</loc>
    <lastmod>2026-11-11</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/pancreatic-colorectal-cancer-insight-esmo</loc>
    <lastmod>2026-11-11</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/gsk-rsv-awareness-japan-survey</loc>
    <lastmod>2026-11-11</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/eu-medicine-reform-8plus1-years</loc>
    <lastmod>2026-11-11</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/novartis-access-medicine-index-2026</loc>
    <lastmod>2026-11-11</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/rwe-asset-simon-kucher-pillars</loc>
    <lastmod>2026-11-11</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/esmo-2026-99-events-392page</loc>
    <lastmod>2026-11-11</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/gsk-access-index-2026-second</loc>
    <lastmod>2026-11-11</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/jnj-caplyta-bipolar-manic-phase3</loc>
    <lastmod>2026-11-11</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/novartis-inalumab-sjogrens-108week</loc>
    <lastmod>2026-11-11</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/tsumura-interim-1034-okuyen</loc>
    <lastmod>2026-11-11</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/kakensei-interim-profit-guidance</loc>
    <lastmod>2026-11-11</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/mochida-interim-sales-profit-growth</loc>
    <lastmod>2026-11-11</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/bms-pediatric-hocm-phase3-56-week-data</loc>
    <lastmod>2026-11-10</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/roche-ctad-nlrp3-inhibitor-alzheimers</loc>
    <lastmod>2026-11-10</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/heartseed-hs001-ips-cardiac</loc>
    <lastmod>2026-11-10</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/boehringer-oral-anticancer-adherence-seal</loc>
    <lastmod>2026-11-10</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/ubie-ntt-ai-medical-platform</loc>
    <lastmod>2026-11-10</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/amgen-repatha-cost-effectiveness-analysis</loc>
    <lastmod>2026-11-10</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/fda-sanhalbo-fxia-inhibitor-stroke</loc>
    <lastmod>2026-11-10</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/oncolys-telomelase-laryngeal-trial</loc>
    <lastmod>2026-11-10</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/asuka-infertility-management-training</loc>
    <lastmod>2026-11-10</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/takeda-ceo-women-leadership-council</loc>
    <lastmod>2026-11-10</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/boehringer-survodutide-phase3-lancet</loc>
    <lastmod>2026-11-10</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/hutchmed-syk-inhibitor-itp-orphan</loc>
    <lastmod>2026-11-10</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/jnj-prostate-cancer-psa-73percent</loc>
    <lastmod>2026-11-10</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/kyorin-pharma-eb05-ards</loc>
    <lastmod>2026-11-10</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/kyorin-pharma-operating-loss-revision</loc>
    <lastmod>2026-11-09</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/shionogi-cobgos-lp-approval</loc>
    <lastmod>2026-11-09</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/efpia-japan-women-hemophilia-seminar</loc>
    <lastmod>2026-11-09</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/tanabe-obesity-academic-partnership</loc>
    <lastmod>2026-11-09</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/lilly-insulin-50-year-award</loc>
    <lastmod>2026-11-09</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/ucb-biogen-trm-sle-dzp-response</loc>
    <lastmod>2026-11-09</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/ucb-bimekizumab-acr50-54percent</loc>
    <lastmod>2026-11-09</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/msd-moderna-neoantigen-42percent</loc>
    <lastmod>2026-11-09</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/kakensei-artham-merger-december</loc>
    <lastmod>2026-11-09</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/asuka-pharma-ics-amed-grit</loc>
    <lastmod>2026-11-09</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/innovacell-icef16-phase1-ild</loc>
    <lastmod>2026-11-09</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/eisai-cognition-diet-behavior</loc>
    <lastmod>2026-11-09</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/lilly-tanabe-mounjaro-supply-review</loc>
    <lastmod>2026-11-09</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/lilly-tanabe-pharma-supply-review-improper</loc>
    <lastmod>2026-11-09</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/allergan-glp1-aesthetic-satisfaction</loc>
    <lastmod>2026-11-09</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/jnj-nipocalimab-phase2-oral-dryness</loc>
    <lastmod>2026-11-08</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/jnj-icotidin-psoriatic-arthritis-phase3</loc>
    <lastmod>2026-11-08</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/chuikyo-new-drugs-lecanemab-27141</loc>
    <lastmod>2026-11-08</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/blockbuster-after-three-pillars-ipsos</loc>
    <lastmod>2026-11-07</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/oncolis-3q-sales-loss-narrow</loc>
    <lastmod>2026-11-07</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/novo-mash-semaglutide-ast-weight-reduction</loc>
    <lastmod>2026-11-07</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/gilead-lenacapavir-continuation-rate</loc>
    <lastmod>2026-11-07</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/moderna-3q-profit-guidance-raised</loc>
    <lastmod>2026-11-07</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/silchester-sawai-ghd-stake-dividend</loc>
    <lastmod>2026-11-07</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/chuikyo-biosimilar-insurance-coverage-review</loc>
    <lastmod>2026-11-07</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/olaparib-immunotherapy-synergy-trial</loc>
    <lastmod>2026-11-06</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/innovacell-co-ceo-interview</loc>
    <lastmod>2026-11-06</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/qualips-reheart-third-transplant</loc>
    <lastmod>2026-11-06</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/gsk-2026-q3-sales-guidance</loc>
    <lastmod>2026-11-06</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/jnj-amivantamab-head-neck-fda</loc>
    <lastmod>2026-11-06</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/gni-gyre-f351-approval-2027</loc>
    <lastmod>2026-11-06</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/merck-infertility-work-balance-survey</loc>
    <lastmod>2026-11-06</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/umu-ai-management-dojo-pharma</loc>
    <lastmod>2026-11-06</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/novartis-cml-patient-forum-qol</loc>
    <lastmod>2026-11-06</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/ipsen-pbc-phase3-alp-normalization</loc>
    <lastmod>2026-11-06</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/viatris-3q-flat-wakix-approval</loc>
    <lastmod>2026-11-06</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/amgen-repatha-20percent-mi-reduction</loc>
    <lastmod>2026-11-06</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/gilead-seladelpar-ideal-trial-alp</loc>
    <lastmod>2026-11-06</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/peptidream-msd-milestone-phase1</loc>
    <lastmod>2026-11-06</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/viatris-3q-sales-guidance-raised</loc>
    <lastmod>2026-11-06</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/gsk-aasld-liver-disease-21</loc>
    <lastmod>2026-11-06</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/lilly-imraldi-oral-serd-launch</loc>
    <lastmod>2026-11-05</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/kyowa-kirin-kura-ziftomenib-ash</loc>
    <lastmod>2026-11-05</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/meiji-seika-pharma-cira-extension</loc>
    <lastmod>2026-11-05</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/msd-cervical-cancer-essay-manga</loc>
    <lastmod>2026-11-05</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/helios-dual-car-enk-glioblastoma</loc>
    <lastmod>2026-11-05</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/perseus-ppmx-t003-ash</loc>
    <lastmod>2026-11-05</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/deltafly-dfp-10917-ash-2026</loc>
    <lastmod>2026-11-05</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/genmab-petosemtamab-hnscc-phase3</loc>
    <lastmod>2026-11-05</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/jmdc-mid-term-revenue-growth</loc>
    <lastmod>2026-11-05</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/asuka-pharma-mid-guidance-unchanged</loc>
    <lastmod>2026-11-05</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/astellas-mid-sales-guidance-raised</loc>
    <lastmod>2026-11-05</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/kissei-mid-profit-tabneos</loc>
    <lastmod>2026-11-05</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/sumitomo-pharma-ash-enzomenib</loc>
    <lastmod>2026-11-05</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/tanabe-pharma-yakki-ai-agent</loc>
    <lastmod>2026-11-05</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/ono-sapablursen-pv-orphan</loc>
    <lastmod>2026-11-05</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/taihobotec-azacitidine-aztound-ash</loc>
    <lastmod>2026-11-05</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/kissei-tabaris-ash-annual-meeting</loc>
    <lastmod>2026-11-05</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/shionogi-retirement-age-employment-reform</loc>
    <lastmod>2026-11-05</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/rhythm-imcivrep-sales-japan</loc>
    <lastmod>2026-11-05</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/ultragenyx-q3-2026-revenue-workforce</loc>
    <lastmod>2026-11-05</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/nexera-fy2026-guidance-abbvie</loc>
    <lastmod>2026-11-05</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/asuka-bayer-veelnaraa-license</loc>
    <lastmod>2026-11-05</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/ultragenyx-rd-cost-reduction</loc>
    <lastmod>2026-11-05</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/boehringer-sbp-cancer-drug</loc>
    <lastmod>2026-11-05</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/evaluate-q4-2026-catalysts</loc>
    <lastmod>2026-11-05</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/zs-zaidyn-autonomous-ai-expansion</loc>
    <lastmod>2026-11-05</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/gilead-kite-ash-2026-anito-cel</loc>
    <lastmod>2026-11-05</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/deloitte-physician-survey-ai-information</loc>
    <lastmod>2026-11-05</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/genmab-epcoritamab-ash-2026</loc>
    <lastmod>2026-11-05</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/ucb-cradle-ai-antibody-design</loc>
    <lastmod>2026-11-04</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/m3-mid-sales-up-profit-down</loc>
    <lastmod>2026-11-04</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/jpma-newsletter-november-npo-transition</loc>
    <lastmod>2026-11-04</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/carenet-cloud-breach-investigation</loc>
    <lastmod>2026-11-04</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/nexera-ep4-agonist-abbvie-license</loc>
    <lastmod>2026-11-04</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/novo-fy-guidance-raised-q3-operating-profit</loc>
    <lastmod>2026-11-04</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/asuka-pharma-thyroid-eye-disease-drug</loc>
    <lastmod>2026-11-04</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/txp-medical-japan-rwe-whitepaper</loc>
    <lastmod>2026-11-04</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/ai-search-pharma-wholesalers-four-major</loc>
    <lastmod>2026-11-04</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/otsuka-renal-denervation-paradise</loc>
    <lastmod>2026-11-04</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/jmdc-sumitomo-influenza-data</loc>
    <lastmod>2026-11-04</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/imdetoral-imfinzi-es-sclc</loc>
    <lastmod>2026-11-04</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/evaluate-pharma-investment-q3-2026</loc>
    <lastmod>2026-11-04</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/amgen-3q-revenue-10-4-billion-eps</loc>
    <lastmod>2026-11-04</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/novartis-bioarctic-cns-delivery</loc>
    <lastmod>2026-11-04</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/teva-innovative-drugs-guidance-raised</loc>
    <lastmod>2026-11-04</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/teva-samsung-bioepis-us-contract</loc>
    <lastmod>2026-11-04</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/pfizer-3q-flat-guidance-raised</loc>
    <lastmod>2026-11-04</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/allergan-aesthetics-asds-9-presentations</loc>
    <lastmod>2026-11-04</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/hutchmed-astrazeneca-savolitinib-approval</loc>
    <lastmod>2026-11-03</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/otsuka-pharma-fukui-gym-health-program</loc>
    <lastmod>2026-11-03</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/cro-selection-ai-top-two-companies</loc>
    <lastmod>2026-11-03</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/gilead-hiv-glasgow-2026-trials</loc>
    <lastmod>2026-11-03</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/lek-clinical-trial-ai-measurement</loc>
    <lastmod>2026-11-03</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/bcg-medtech-ai-model-ebitda</loc>
    <lastmod>2026-11-03</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/deloitte-anaplan-pharma-planning</loc>
    <lastmod>2026-11-03</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/santen-myopia-eyedrop-korea-approval</loc>
    <lastmod>2026-11-03</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/teva-emrusolmin-phase2-discontinued</loc>
    <lastmod>2026-11-03</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/kyowa-kirin-q3-revenue-growth</loc>
    <lastmod>2026-11-02</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/hgpi-rare-disease-medical-system-proposal</loc>
    <lastmod>2026-11-02</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/bimekizumab-psa-risankizumab-acr50</loc>
    <lastmod>2026-11-02</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/medii-neuroimmunology-case-consultation</loc>
    <lastmod>2026-11-02</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/s-racmo-takara-bio-cell-processing</loc>
    <lastmod>2026-11-02</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/mdv-diabetes-acute-complication-analysis</loc>
    <lastmod>2026-11-02</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/mdv-db-patients-9-05-million</loc>
    <lastmod>2026-11-02</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/daiichi-sankyo-mid-term-revenue-growth</loc>
    <lastmod>2026-11-02</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/jnj-impella-clinical-data-tct-2026</loc>
    <lastmod>2026-11-02</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/fda-voceryq-plasmid-dna-rp-approval</loc>
    <lastmod>2026-10-31</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/drug-development-council-manufacturing</loc>
    <lastmod>2026-10-31</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/otsuka-hd-sales-2-trillion</loc>
    <lastmod>2026-10-31</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/zs-sga-investment-allocation</loc>
    <lastmod>2026-10-31</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/enhertz-biotech-award-galien-international</loc>
    <lastmod>2026-10-31</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/regeneron-q3-revenue-growth-sanofi-expansion</loc>
    <lastmod>2026-10-31</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/sumitomo-pharma-h1-guidance</loc>
    <lastmod>2026-10-31</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/abbvie-q3-2026-revenue-growth-eps-guidance</loc>
    <lastmod>2026-10-31</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/mckinsey-hospital-conference-tokyo</loc>
    <lastmod>2026-10-30</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/sanofi-q3-revenue-guidance-2026</loc>
    <lastmod>2026-10-30</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/meiji-seika-pharma-defamation-verdict</loc>
    <lastmod>2026-10-30</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/novartis-pharma-ceo-transition</loc>
    <lastmod>2026-10-30</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/sanofi-teva-duvakitug-maintenance-data</loc>
    <lastmod>2026-10-30</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/jnj-nipocalimab-gmg-2year-results</loc>
    <lastmod>2026-10-30</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/sumitomo-pharma-guidance-up</loc>
    <lastmod>2026-10-30</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/astrazeneca-q3-sales-growth</loc>
    <lastmod>2026-10-30</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/longevity-pharma-lek-analysis</loc>
    <lastmod>2026-10-30</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/eisai-lecanemab-ctad-2026</loc>
    <lastmod>2026-10-30</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/hbi-8000-nivolumab-melanoma-pfs</loc>
    <lastmod>2026-10-30</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/gilead-3q-revenue-8-3-billion</loc>
    <lastmod>2026-10-30</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/chuikyo-cost-effectiveness-fy2027</loc>
    <lastmod>2026-10-30</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/chuikyo-drug-price-fy2027-supply</loc>
    <lastmod>2026-10-30</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/chuikyo-zolgensma-cost-effectiveness</loc>
    <lastmod>2026-10-30</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/bms-q3-2026-revenue-growth-guidance-raised</loc>
    <lastmod>2026-10-30</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/lilly-3q-revenue-244-billion-guidance</loc>
    <lastmod>2026-10-30</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/novo-obesity-week-2026-presentations</loc>
    <lastmod>2026-10-30</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/biogen-q3-revenue-growth-eps-guidance</loc>
    <lastmod>2026-10-29</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/takeda-fy2026-h1-earnings-guidance</loc>
    <lastmod>2026-10-29</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/shionogi-generic-drug-business-divestiture</loc>
    <lastmod>2026-10-29</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/shionogi-fy2027-guidance-dividend</loc>
    <lastmod>2026-10-29</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/jcr-pharma-fy2027-q2-operating-loss</loc>
    <lastmod>2026-10-29</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/tanabe-pharma-anti-cd19-adc</loc>
    <lastmod>2026-10-29</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/kissei-pharma-interim-earnings-revision</loc>
    <lastmod>2026-10-29</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/fronteo-maruho-dermatology-drug-discovery</loc>
    <lastmod>2026-10-29</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/prostate-cancer-brochure-radiation-therapy</loc>
    <lastmod>2026-10-29</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/gsk-b7h4-adc-ovarian-cancer</loc>
    <lastmod>2026-10-29</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/gsk-q3-sales-growth</loc>
    <lastmod>2026-10-29</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/ono-ono-1110-five-phase2-trials</loc>
    <lastmod>2026-10-29</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/astellas-patient-centricity-article</loc>
    <lastmod>2026-10-29</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/retatrutide-ozempic-superiority-phase3</loc>
    <lastmod>2026-10-29</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/lek-pharmadj-china-clinical-development</loc>
    <lastmod>2026-10-29</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/novo-glp1-appropriate-use-supply</loc>
    <lastmod>2026-10-29</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/rohto-exosome-jsev-award</loc>
    <lastmod>2026-10-29</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/novo-aasld-2026-mash-presentations</loc>
    <lastmod>2026-10-29</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/evaluate-ci-productivity-report</loc>
    <lastmod>2026-10-29</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/copernicus-kyorin-10-percent</loc>
    <lastmod>2026-10-29</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/silchester-santen-10-25-percent</loc>
    <lastmod>2026-10-29</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/eisai-lecanemab-sales-61-5-billion</loc>
    <lastmod>2026-10-29</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/medii-irae-consultation-analysis</loc>
    <lastmod>2026-10-28</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/roche-mesothelioma-ihc-diagnostic-test</loc>
    <lastmod>2026-10-28</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/j-tec-maruho-jasmine-vitiligo-contract</loc>
    <lastmod>2026-10-28</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/china-medical-device-early-access-boao</loc>
    <lastmod>2026-10-28</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/tsumura-fy2027-guidance-upward-revision</loc>
    <lastmod>2026-10-28</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/mochida-qilu-biosimilar-partnership</loc>
    <lastmod>2026-10-28</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/alkermes-digital-biomarker-autoimmune</loc>
    <lastmod>2026-10-28</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/nexera-lucerastat-fabry-disease</loc>
    <lastmod>2026-10-28</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/gsk-fy2026-q3-hibsago-japan</loc>
    <lastmod>2026-10-28</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/astellas-audax-dax-044-exclusive-option</loc>
    <lastmod>2026-10-28</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/abbvie-etenimig-bcma-bla</loc>
    <lastmod>2026-10-28</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/qualips-reheart-transplant</loc>
    <lastmod>2026-10-28</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/amgen-acr-2026-sjogren</loc>
    <lastmod>2026-10-28</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/fronteo-otsuka-renal-discovery</loc>
    <lastmod>2026-10-27</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/chugai-q3-sales-1-trillion-yen</loc>
    <lastmod>2026-10-27</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/enhertz-her2-early-breast-cancer-approval</loc>
    <lastmod>2026-10-27</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/heartseed-hs-005-ischemic-heart</loc>
    <lastmod>2026-10-27</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/novartis-q3-core-profit-up</loc>
    <lastmod>2026-10-27</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/novartis-coartem-baby-who-prequalification</loc>
    <lastmod>2026-10-27</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/astellas-fezolinetant-china-nda</loc>
    <lastmod>2026-10-27</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/jpma-adverse-event-evaluation-process</loc>
    <lastmod>2026-10-27</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/sumitomo-pharma-enzomenib-breakthrough</loc>
    <lastmod>2026-10-27</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/mckinsey-pharma-operations-japan</loc>
    <lastmod>2026-10-27</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/cisplatin-ineligible-bladder-cancer-volga</loc>
    <lastmod>2026-10-27</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/astrazeneca-tagrisso-orpathie-lung-cancer</loc>
    <lastmod>2026-10-27</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/astrazeneca-cldn18-2-gastric-cancer</loc>
    <lastmod>2026-10-27</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/gsk-b7h3-adc-osteosarcoma-phase3</loc>
    <lastmod>2026-10-27</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/enhertu-eu-her2-early-breast-cancer</loc>
    <lastmod>2026-10-27</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/biontech-duality-trastuzumab-pamilrceltic-phase3</loc>
    <lastmod>2026-10-27</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/chugai-roche-safacetselsenna-phase3</loc>
    <lastmod>2026-10-26</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/otsuka-pharma-biov-launch</loc>
    <lastmod>2026-10-26</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/mochida-bon-001-hyperemesis-phase3</loc>
    <lastmod>2026-10-26</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/takeda-cldn18-2-gastric-cancer-adc</loc>
    <lastmod>2026-10-26</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/pmda-emergency-system-suspension-security</loc>
    <lastmod>2026-10-26</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/lilly-mirikizumab-pediatric-ulcerative-colitis-phase3</loc>
    <lastmod>2026-10-26</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/nice-oral-gnrh-antagonist-prescription</loc>
    <lastmod>2026-10-26</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/asahi-kasei-mpgn-c3-glomerulonephritis</loc>
    <lastmod>2026-10-26</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/roche-divarasib-phase3-sotorasib-os</loc>
    <lastmod>2026-10-26</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/jnj-amivantamab-head-neck-cancer-orr</loc>
    <lastmod>2026-10-26</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/genmab-petosemtamab-colorectal-cancer</loc>
    <lastmod>2026-10-26</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/pomitamig-docetaxel-nsclc-2l</loc>
    <lastmod>2026-10-25</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/gsk-rectal-cancer-azur1-results</loc>
    <lastmod>2026-10-25</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/jnj-proteus-apalutamide-recurrence-risk</loc>
    <lastmod>2026-10-25</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/talquetamab-maintenance-os-reduction</loc>
    <lastmod>2026-10-25</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/genmab-incyte-kras-g12d-colorectal</loc>
    <lastmod>2026-10-25</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/fda-skyrizi-crohns-disease-subcutaneous</loc>
    <lastmod>2026-10-24</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/ema-ama-bundibugyo-ebola-vaccine</loc>
    <lastmod>2026-10-24</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/genmab-rina-s-ovarian-cancer</loc>
    <lastmod>2026-10-24</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/roche-cephacelselsenna-iga-nephropathy</loc>
    <lastmod>2026-10-24</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/jnj-esmo-2026-riptac-data</loc>
    <lastmod>2026-10-24</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/novartis-remibrutinib-phase3-rms</loc>
    <lastmod>2026-10-24</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/kisqali-early-breast-cancer-natalee</loc>
    <lastmod>2026-10-24</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/nippon-shinyaku-digital-ennnichi-event</loc>
    <lastmod>2026-10-23</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/alexion-pharma-diagnostic-lag-book</loc>
    <lastmod>2026-10-23</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/rakuten-medical-asp-1929-esmo-2026</loc>
    <lastmod>2026-10-23</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/e-projection-mfn-policy-japan-report</loc>
    <lastmod>2026-10-23</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/toho-holdings-integrated-report-2026</loc>
    <lastmod>2026-10-23</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/nice-prostate-mri-ai-nhs-conditional</loc>
    <lastmod>2026-10-23</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/enfortumab-vedotin-pembrolizumab-mibc-eu</loc>
    <lastmod>2026-10-23</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/otsuka-sibeprenlimab-renal-event-reduction</loc>
    <lastmod>2026-10-23</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/personalized-mrna-phase3-merck-moderna</loc>
    <lastmod>2026-10-23</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/evaluate-2027-launch-candidates-60</loc>
    <lastmod>2026-10-23</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/fda-nain-neuroscience-product-development</loc>
    <lastmod>2026-10-23</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/abbvie-risankizumab-hidradenitis-phase3</loc>
    <lastmod>2026-10-23</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/ultomiris-iga-nephropathy-approval</loc>
    <lastmod>2026-10-23</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/ipsen-sales-growth-9m-profit</loc>
    <lastmod>2026-10-23</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/biontech-tnbc-gilead-adc</loc>
    <lastmod>2026-10-23</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/gilead-hcxt-2001-il-23r-acquisition</loc>
    <lastmod>2026-10-23</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/jnj-acr2026-icotyde-psa</loc>
    <lastmod>2026-10-23</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/jnj-pfa-aphrs2026-varipulse-pro</loc>
    <lastmod>2026-10-23</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/gilead-aasld2026-pbc-phase3-ideal</loc>
    <lastmod>2026-10-23</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/tabneos-new-dosing-mhlw-notice</loc>
    <lastmod>2026-10-23</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/biontech-mrna-manufacturing-victoria</loc>
    <lastmod>2026-10-23</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/brightpath-ips-car-nkt-jitc</loc>
    <lastmod>2026-10-23</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/helios-enk-cell-distribution-direct-qpcr</loc>
    <lastmod>2026-10-22</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/nexera-vamoralone-korea-approval</loc>
    <lastmod>2026-10-22</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/ribomics-achondroplasia-phase3-enrollment</loc>
    <lastmod>2026-10-22</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/biken-tanabe-pharma-hexavalent-vaccine</loc>
    <lastmod>2026-10-22</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/new-modality-pipeline-value-bcg-2026</loc>
    <lastmod>2026-10-22</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/roche-q3-sales-growth-japan-strong</loc>
    <lastmod>2026-10-22</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/ucb-2026-guidance-sales-growth</loc>
    <lastmod>2026-10-22</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/steboronin-recurrent-meningioma-approval</loc>
    <lastmod>2026-10-22</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/enhertz-china-her2-solid-tumor-approval</loc>
    <lastmod>2026-10-22</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/roche-fenebrutinib-mstoronto2026</loc>
    <lastmod>2026-10-22</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/novartis-cosentyx-pmr-eu-approval</loc>
    <lastmod>2026-10-22</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/fda-climara-pro-generic-approval</loc>
    <lastmod>2026-10-22</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/openai-orchestra-bio-rosalind</loc>
    <lastmod>2026-10-21</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/shionogi-olorofim-phase3-asia-europe</loc>
    <lastmod>2026-10-21</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/shionogi-ensitrelvir-idweek2026</loc>
    <lastmod>2026-10-21</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/sanofi-weiliz-btk-inhibitor-itp</loc>
    <lastmod>2026-10-21</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/shionogi-cefiderocol-idweek2026</loc>
    <lastmod>2026-10-21</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/hisamitsu-hp-5120-phase2-japan</loc>
    <lastmod>2026-10-21</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/m3-studio-cloud-unauthorized-access</loc>
    <lastmod>2026-10-21</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/heartseed-ips-cardiomyocyte-iscience</loc>
    <lastmod>2026-10-21</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/gsk-hisbago-hepatitis-b-approval</loc>
    <lastmod>2026-10-21</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/novo-cagrisema-weight-reduction-redefine</loc>
    <lastmod>2026-10-21</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/tezspire-eosinophilic-esophagitis-phase3</loc>
    <lastmod>2026-10-21</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/duvakitug-uc-cd-phase2b-long-term</loc>
    <lastmod>2026-10-21</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/carcirla-subcutaneous-carclic-device</loc>
    <lastmod>2026-10-21</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/takeda-entyvio-verdict-complication-risk</loc>
    <lastmod>2026-10-20</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/jnj-guselkumab-fistula-48week-data</loc>
    <lastmod>2026-10-20</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/gsk-jemperli-fda-approval-msi-h-rectal</loc>
    <lastmod>2026-10-20</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/takeda-tak-881-phase2-3-results</loc>
    <lastmod>2026-10-20</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/takeda-ozeiflur-nt1-japan-china</loc>
    <lastmod>2026-10-20</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/rhythmfarm-imsibrylee-hypothalamic-obesity</loc>
    <lastmod>2026-10-19</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/abbvie-abbv-466-phase2a-remission</loc>
    <lastmod>2026-10-19</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/roche-krras-g12c-esmo2026</loc>
    <lastmod>2026-10-19</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/gilead-oral-a4b7-uc-phase2</loc>
    <lastmod>2026-10-19</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/toho-entouch-unauthorized-access</loc>
    <lastmod>2026-10-19</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/fujifilm-ai-document-ep-pharma</loc>
    <lastmod>2026-10-19</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/abbvie-esmo2026-solid-cancers</loc>
    <lastmod>2026-10-19</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/gsk-ris-rez-b7-h3-adc</loc>
    <lastmod>2026-10-19</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/jnj-q4-2026-dividend-1-34</loc>
    <lastmod>2026-10-19</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/jnj-2026-sales-1-trillion-yen</loc>
    <lastmod>2026-10-19</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/novartis-favipiravir-iga-nephropathy</loc>
    <lastmod>2026-10-19</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/jnj-icotyde-oral-2-year</loc>
    <lastmod>2026-10-18</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/jnj-icotydeq-2-year-data</loc>
    <lastmod>2026-10-18</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/ucb-bimekizumab-hs-eadv2026</loc>
    <lastmod>2026-10-18</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/jnj-imaavy-gmg-2-year</loc>
    <lastmod>2026-10-18</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/abbvie-ibd-uegw2026-long-term</loc>
    <lastmod>2026-10-17</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/viatris-rhythmvae-presbyopia-fda</loc>
    <lastmod>2026-10-17</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/gsk-esmo2026-solid-tumors</loc>
    <lastmod>2026-10-17</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/ema-chmp-6-new-drugs-positive-opinion</loc>
    <lastmod>2026-10-17</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/ema-chmp-talquetamab-daratumumab</loc>
    <lastmod>2026-10-17</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/m3-mr-kun-unauthorized-access</loc>
    <lastmod>2026-10-17</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/enspryng-thyroid-eye-disease-fda-roche</loc>
    <lastmod>2026-10-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/amgen-obesity-disorder-agreement-japan</loc>
    <lastmod>2026-10-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/pwc-china-drug-discovery-11-approvals</loc>
    <lastmod>2026-10-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/fda-enspryng-thyroid-eye-roche</loc>
    <lastmod>2026-10-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/ucb-zilbrysq-auto-injector-gmg</loc>
    <lastmod>2026-10-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/toho-adiposeeds-venture-investment</loc>
    <lastmod>2026-10-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/eisai-lenvima-phase3-esmo2026</loc>
    <lastmod>2026-10-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/eisai-lenvima-rcc-phase3-esmo2026</loc>
    <lastmod>2026-10-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/emsree-mr-kun-unauthorized-access</loc>
    <lastmod>2026-10-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/otsuka-recordl-renal-denervation-time</loc>
    <lastmod>2026-10-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/ema-rasokine-oral-ras-inhibitor</loc>
    <lastmod>2026-10-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/chordia-fy2026-operating-loss</loc>
    <lastmod>2026-10-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/male-stress-incontinence-device-approval</loc>
    <lastmod>2026-10-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/takeda-tak-881-pid-phase2-3</loc>
    <lastmod>2026-10-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/takeda-ouseifuru-nt1-japan-china</loc>
    <lastmod>2026-10-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/jnj-tremfya-crohn-disease-fistula</loc>
    <lastmod>2026-10-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/tremfya-crohns-remission-3-year</loc>
    <lastmod>2026-10-16</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/fda-rare-disease-development-framework</loc>
    <lastmod>2026-10-15</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/nexera-daridorexant-apac-synmosa</loc>
    <lastmod>2026-10-15</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/jpharm-namblumlat-phase3-japan-korea</loc>
    <lastmod>2026-10-15</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/imcivree-acquired-hypothalamic-obesity</loc>
    <lastmod>2026-10-14</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/abbvie-skyrizi-affirm-induction-remission</loc>
    <lastmod>2026-10-14</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/jnj-q3-sales-growth-5-9-percent</loc>
    <lastmod>2026-10-14</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/moderna-xfg-pediatric-covid-vaccine</loc>
    <lastmod>2026-10-14</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/tegoprazan-nerd-phase3-acg2026</loc>
    <lastmod>2026-10-14</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/tecvayli-dalakiruci-pfs-24-month</loc>
    <lastmod>2026-10-14</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/copay-burden-70-plus-elderly</loc>
    <lastmod>2026-10-14</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/ai-mr-meeting-record-structure</loc>
    <lastmod>2026-10-13</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/bms-ryz101-pfs-gep-nets</loc>
    <lastmod>2026-10-13</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/abbvie-skyrizi-affirm-ibd-data</loc>
    <lastmod>2026-10-12</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/jpharm-namblumlat-international-phase3</loc>
    <lastmod>2026-10-11</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/e7386-lenvatinib-orr-36-7-percent</loc>
    <lastmod>2026-10-11</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/mochida-refeel-pbc-biomed-partnership</loc>
    <lastmod>2026-10-11</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/viatris-pasica-1650m-nonopioid</loc>
    <lastmod>2026-10-11</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/ono-biohaven-igg-degrader-license</loc>
    <lastmod>2026-10-11</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/veeva-ai-agent-trial-setup</loc>
    <lastmod>2026-10-11</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/enhertz-her2-positive-ebc-approval-china</loc>
    <lastmod>2026-10-11</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/datroway-tnbc-approval-china</loc>
    <lastmod>2026-10-11</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/abbvie-temab-a-crc-nsclc-fda-breakthrough</loc>
    <lastmod>2026-10-08</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/jcr-forecast-revision-drug-price</loc>
    <lastmod>2026-10-08</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/jcr-growtropin-turner-syndrome</loc>
    <lastmod>2026-10-08</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/otsuka-voyxact-us-sbla-submission</loc>
    <lastmod>2026-10-08</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/steboronin-recurrent-meningioma-stellapharm</loc>
    <lastmod>2026-10-08</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/fda-remibrutinib-symptomatic-dermographism</loc>
    <lastmod>2026-10-08</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/chuikyo-14-new-drugs-october</loc>
    <lastmod>2026-10-08</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/chuikyo-drug-price-fy2027-new-drugs</loc>
    <lastmod>2026-10-08</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/shionogi-ashtea-mite-sublingual-seoria</loc>
    <lastmod>2026-10-08</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/neuroimmune-subscription-warrant-okasan</loc>
    <lastmod>2026-10-08</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/helios-culture-supernatant-sales</loc>
    <lastmod>2026-10-08</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/jpharm-amed-grit-15-billion-yen</loc>
    <lastmod>2026-10-08</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/carnabio-monzosertib-european-patent</loc>
    <lastmod>2026-10-08</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/chuikyo-repatha-gcp-advanced-medicine</loc>
    <lastmod>2026-10-08</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/chuikyo-cost-increase-price-adjustment</loc>
    <lastmod>2026-10-08</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/shionogi-intrabio-acquisition-aqneursa</loc>
    <lastmod>2026-10-06</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/chuikyo-cost-effectiveness-evaluation-49-items</loc>
    <lastmod>2026-09-09</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/otc-similar-drugs-separate-burden-reiwa9</loc>
    <lastmod>2026-09-09</lastmod>
  </url>
  <url>
    <loc>https://whattonoh.jp/articles/juntendo-carenet-ai-clinical-support</loc>
    <lastmod>2026-09-08</lastmod>
  </url>
</urlset>